Are there markers for exceptional responders available for attending pathologists?

摘要：

In the records of the recent rampant clinical trials, people have noticed there is a fraction, though small, who have extremely good responses to the drugs. The definition of this population "Cancer exceptional responder" is proposed and feasibility study has been launched[1]. Definition there is not particularly hard ones.

所属期刊栏目：41

资助基金：Some of the content is supported by the SRF

在线出版日期：2021-12-20（万方平台首次上网日期，不代表论文的发表时间）

页数：共3页

页码：2497-2499